Synthetic hyperacetylation of nucleosomal histones.


Journal

RSC chemical biology
ISSN: 2633-0679
Titre abrégé: RSC Chem Biol
Pays: England
ID NLM: 101768727

Informations de publication

Date de publication:
01 Jun 2020
Historique:
received: 11 03 2020
accepted: 29 04 2020
entrez: 30 8 2021
pubmed: 19 5 2020
medline: 19 5 2020
Statut: epublish

Résumé

We report combinations of a DMAP-based catalyst and phenyl acetate with optimal electron density as a new chemical system for high-yield, selective synthetic acetylation of histone lysine residues. The utility of this chemical system as a unique biologic tool is demonstrated by applying it to

Identifiants

pubmed: 34458748
doi: 10.1039/d0cb00029a
pii: d0cb00029a
pmc: PMC8341002
doi:

Types de publication

Journal Article

Langues

eng

Pagination

56-59

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

There are no conflicts to declare.

Références

Genetics. 1982 Apr;100(4):547-63
pubmed: 6749598
FEBS Lett. 2018 Feb;592(4):475-488
pubmed: 29119545
J Am Chem Soc. 2011 Aug 10;133(31):12220-8
pubmed: 21761940
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5723-7
pubmed: 2762292
Tetrahedron. 1967 Jun;23(6):2855-61
pubmed: 6047529
J Exp Zool. 1982 Aug 10;222(2):173-86
pubmed: 7130928
Trends Cell Biol. 1997 Jun;7(6):230-6
pubmed: 17708951
Nat Rev Mol Cell Biol. 2013 May;14(5):269-82
pubmed: 23594953
EMBO Rep. 2007 Feb;8(2):165-72
pubmed: 17235358
Nat Rev Mol Cell Biol. 2015 Jun;16(6):360-74
pubmed: 25999062
J Cell Biol. 1985 Aug;101(2):518-23
pubmed: 3926780
Cell. 2012 Jul 6;150(1):12-27
pubmed: 22770212
Nat Methods. 2016 Feb;13(2):158-64
pubmed: 26727110
Biochim Biophys Acta. 1998 Jun 16;1398(2):113-36
pubmed: 9689912
Nat Chem. 2015 May;7(5):394-402
pubmed: 25901817
Nature. 2009 May 7;459(7243):113-7
pubmed: 19270680

Auteurs

Hidetoshi Kajino (H)

Graduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan yamatsugu@mol.f.u-tokyo.ac.jp skawashima@mol.f.u-tokyo.ac.jp kanai@mol.f.u-tokyo.ac.jp.

Tomomi Nagatani (T)

Division of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo 4-6-1 Shiroganedai Minato-ku Tokyo 108-8639 Japan.

Miku Oi (M)

Graduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan yamatsugu@mol.f.u-tokyo.ac.jp skawashima@mol.f.u-tokyo.ac.jp kanai@mol.f.u-tokyo.ac.jp.

Tomoya Kujirai (T)

Institute for Quantitative Biosciences, The University of Tokyo 1-1-1 Yayoi Bunkyo-ku Tokyo 113-0032 Japan.
JST-ERATO, KURUMIZAKA Chromatin Atlas 1-1-1 Yayoi Bunkyo-ku Tokyo 113-0032 Japan.

Hitoshi Kurumizaka (H)

Institute for Quantitative Biosciences, The University of Tokyo 1-1-1 Yayoi Bunkyo-ku Tokyo 113-0032 Japan.
JST-ERATO, KURUMIZAKA Chromatin Atlas 1-1-1 Yayoi Bunkyo-ku Tokyo 113-0032 Japan.

Atsuya Nishiyama (A)

Division of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo 4-6-1 Shiroganedai Minato-ku Tokyo 108-8639 Japan.

Makoto Nakanishi (M)

Division of Cancer Cell Biology, The Institute of Medical Science, The University of Tokyo 4-6-1 Shiroganedai Minato-ku Tokyo 108-8639 Japan.

Kenzo Yamatsugu (K)

Graduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan yamatsugu@mol.f.u-tokyo.ac.jp skawashima@mol.f.u-tokyo.ac.jp kanai@mol.f.u-tokyo.ac.jp.

Shigehiro A Kawashima (SA)

Graduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan yamatsugu@mol.f.u-tokyo.ac.jp skawashima@mol.f.u-tokyo.ac.jp kanai@mol.f.u-tokyo.ac.jp.

Motomu Kanai (M)

Graduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan yamatsugu@mol.f.u-tokyo.ac.jp skawashima@mol.f.u-tokyo.ac.jp kanai@mol.f.u-tokyo.ac.jp.

Classifications MeSH